Chronic obstructive pulmonary disease to drug treatment

Chronic obstructive pulmonary disease to drug treatment
Chronic obstructive pulmonary disease called COPD, including chronic bronchitis and chronic obstructive pulmonary emphysema, is a seriously endanger the health of the people of the common diseases and frequently-occurring disease, the need for the standardization of long-term treatment. In addition to its smoking cessation treatment, rehabilitation training, enhanced physique, attention should be paid to rational drug use.

(1) anti-infection treatment. Man-lung resistance acute exacerbation of the most common cause of respiratory tract infection is, pathogenic micro-organisms is Streptococcus pneumoniae, Haemophilus influenzae, the card he Mora-bacteria, viruses. If time can not be carried out drug sensitivity tests, based on clinical experience administering antibiotics seven to 14 days of treatment, such as amoxicillin, quinolones (such as ciprofloxacin, fluoride Zhen acid, etc.), the new cephalosporins (such as First of the Proton). Macrolides (such as erythromycin ethylsuccinate, ether spiral Adriamycin), aminoglycoside (such as gram of stars, etc.). In recent years due to Staphylococcus aureus, Haemophilus influenzae and resistant Streptococcus, and so has increased, if the initial empirical treatment of poor, should be based on sensitivity test results as soon as possible replacement of the appropriate antibiotics.

(2) spasm asthma. At present there are mainly three types of anti-asthmatic drugs spasm: ① β2 receptor agonists such as salbutamol, such as asthma aerosol Hong speed. ② anticholinergic drugs such as ipratropium bromide, and so on. ③-purine asthma-like distinctions, tea Surge equality. Patients should be based on the individual circumstances choose to use, although not all patients with lung function after treatment will be improved, but can relieve symptoms and improve the ability of the activities.

(3) glucocorticoids, such as prednisone, each weighing 0.4 kg to 0.6 mg daily use, for two to three weeks. If we can significantly improve lung function, may consider long-term application, but it should be timely reduction to the minimum effective level, prevention of complications.

In addition agent may also be used phlegm, mucus dissolved agent with drug treatment to enhance the effect.